NEW YORK (Reuters) - Stocks took off at the end of the week, drawn by
the allure of a helping hand from the world's two most powerful central
banks. Traders are unlikely to resist those charms again next week.
The U.S. Federal Reserve and the European Central Bank
both meet next week amid investor expectations of action to stimulate
economic growth and, in the case of the ECB, tackle the spreading euro
zone debt crisis.
The drumbeat of weak economic data and disappointing
U.S. corporate profits and outlooks mean central banks can be stocks'
best friends.
Equity prices tend to rise sharply in the hours before a
Fed statement like the one expected on Wednesday as traders and
investors jockey for position and a chance to make a profit.
Next week's calendar has a double-whammy. The Fed's
monetary policy statement will come one day before an ECB meeting packed
with intrigue. ECB President Mario Draghi said earlier this week the
bank was ready to do whatever was necessary, within its mandate, to save
the euro.
"People in this business like to get in front of big
events, especially if (they) could be very, very positive for the
market," said Brian Reynolds, chief market strategist at agency
brokerage Rosenblatt Securities.
In that sense the strategy "is almost like a lottery ticket," he said.
But was that ticket already cashed? The S&P 500 (^GSPC) (^INX)
rallied to levels not seen since May on Friday, a rally that was
sparked a day earlier after Draghi stoked expectations the ECB might
resume its Securities Markets Programme (SMP) and possibly adopt more
aggressive quantitative easing.
Reports of meetings with the head of Germany's Bundesbank fueled a Friday rally that outpaced Thursday's gains.
Equity markets have for weeks been leaning on hoped-for
stimulus from the Fed or ECB. Despite weeks of softening economic data,
including a dismal payrolls report for June and a poor outlook for
corporate profits, the S&P 500 has risen in seven of the past 10
weeks. It closed on Friday near a three-month high.
REMARKABLE PATTERN
At the same time that traders position themselves to
benefit from the Fed's latest easy-money policy, those betting against
market gains get out of the way and selling pressure recedes.
"It's very scary to short the market ahead of a Fed
meeting," said Dennis Dick, a proprietary trader at Las Vegas-based
Bright Trading and co-founder of Premarketinfo.com. "So you have this
short-covering that drives prices up."
That helps explain the rise in stocks in the 24 hours
prior to the U.S. central bank's policy decisions - a pattern that tends
to hold irrespective of what the Fed actually says in its statement.
Economists at the Federal Reserve Bank of New York performed a study of the pattern.
Starting mid-afternoon the day before such decisions,
stocks in the United States, Britain, Germany and other major markets
begin a sharp rise and don't stop, on average, until just before the Fed
unveils its policy decision at 2:15 p.m. (1815 GMT) the following day.
Since 1994 a whopping 80 percent of the premium in
gains of U.S. stocks over yields on short-term government bonds has been
earned in these 24-hour periods, the study found.
The pattern has grown starker as the Fed took
increasingly aggressive actions to rescue the U.S. economy from
recession. The two rounds of major asset purchases, known as
quantitative easing, or QE1 and QE2, in recent years strongly boosted
stocks.
"Perhaps this shows markets have given the Fed their
seal of approval," said Brian Jacobsen, chief portfolio strategist at
Wells Fargo Funds Management in Menomonee Falls, Wisconsin.
"At least from a market participant perspective, they
are confident the Fed will fulfill its mandate. I try to talk to
individual investors to remind them that the stock market is going to
react much more quickly than the economy to what the Fed does," he said.
CENTRAL BANKS OVERSHADOW EARNINGS
The focus on central bank meetings will get in the way
of a heavy week of earnings for S&P 500 companies at a time when the
outlook continues to worsen.
Major companies due to report include AIG (AIG), Kellogg (NYS:K), Procter & Gamble (PG), Kraft Foods (KFT.O), Pfizer (PFE), MasterCard (MA) and General Motors (GE).
Among the 290 companies in the S&P 500 index that
have reported earnings for the second quarter, about 67 percent have
beaten analysts' estimates, slightly higher than the long-term average
of about 62 percent.
But just 40 percent have beaten on revenues, the worst record since the first quarter of 2009.
More worrisome is the market's outlook. Third-quarter
earnings are now expected to decline 0.4 percent from a year ago,
compared with an expected rise of 1.4 percent last week, according to
Thomson Reuters data.
Also on investors' radar next week is another legal battle in California over patents between Apple (AAPL)
and South Korea's Samsung <005930.KS>. The trial's outcome could
reshape the smartphone and tablet wars between the iPhone's maker and
its rivals.
No comments:
Post a Comment